Xinrui Chen

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, China Academy of Engineering Physics, Shantou University, Second Affiliated Hospital of Guangzhou Medical University, Cancer Hospital of Shantou University Medical College, First Affiliated Hospital of Guangzhou Medical University, Affiliated Hospital of North Sichuan Medical College, The Affiliated Yongchuan Hospital of Chongqing Medical University, Guangzhou Psychiatric Hospital, Institute of Applied Physics and Computational Mathematics, Fu Wai Hospital, Guangdong 999 Brain Hospital, Chongqing Medical University, Guangzhou Medical University · ORCID：0000-0001-8780-4076

发表论文 102 篇 · 总被引 792 次 · h-index 16

代表论文

• Comparative study on different endoscopic submucosal dissection techniques for the treatment of superficial esophageal cancer and precancerous lesions (2025 · BMC Gastroenterology · 被引 6)
• Safety, pharmacokinetics, and efficacy of abexinostat, an novel histone deacetylase inhibitor, in Chinese patients with relapsed/refractory B cell non-Hodgkin lymphoma: a Phase 1 study (2025 · BMC Cancer · 被引 4)
• Clinical, immune cell, and genetic features predicting survival and long-term response to first-line chemo-immunotherapy treatment for non-small cell lung cancer (2025 · Cancer Immunology Immunotherapy · 被引 4)
• Potential role of hypobaric hypoxia environment in treating pan-cancer (2025 · Scientific Reports · 被引 4)
• Digital spatial profiling uncovers transcriptomic features of distinct plasma cell–like phenotypes in diffuse large B-cell lymphoma (2026 · Blood Advances · 被引 1)
• Silencing of PIGU inhibits the progression of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway (2025 · Scientific Reports · 被引 1)